Related Experiment Video
Updated: Aug 28, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
ΔNp63α in cancer: importance and therapeutic opportunities
Matthew L Fisher1, Seamus Balinth2, Alea A Mills1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Abstract:
Our understanding of cancer and the key pathways that drive cancer survival has expanded rapidly over the past several decades. However, there are still important challenges that continue to impair patient survival, including our inability to target cancer stem cells (CSCs), metastasis, and drug resistance. The transcription factor p63 is a p53 family member with multiple isoforms that carry out a wide array of functions. Here, we discuss the critical importance of the ΔNp63α isoform in cancer and potential therapeutic strategies to target ΔNp63α expression to impair the CSC population, as well as to prevent metastasis and drug resistance to improve patient survival.
Insights
Targeting the ΔNp63α isoform may overcome major cancer challenges. Inhibiting this key protein could reduce cancer stem cells, prevent metastasis, and overcome drug resistance, improving patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer research has advanced significantly, yet challenges like targeting cancer stem cells (CSCs), metastasis, and drug resistance persist.
- The p63 protein, a member of the p53 family, has multiple isoforms with diverse functions.
- The ΔNp63α isoform plays a critical role in various cancers.
Purpose of the Study:
- To highlight the importance of the ΔNp63α isoform in cancer.
- To explore therapeutic strategies targeting ΔNp63α expression.
- To address key challenges in cancer survival: CSCs, metastasis, and drug resistance.
Main Methods:
- Literature review and discussion of existing research on p63 isoforms and cancer pathways.
- Analysis of the role of ΔNp63α in cancer stem cell populations.
- Exploration of potential therapeutic interventions targeting ΔNp63α.
Main Results:
- The ΔNp63α isoform is crucial for cancer cell survival and progression.
- Targeting ΔNp63α presents a promising strategy to inhibit CSCs.
- Inhibition of ΔNp63α may also prevent metastasis and overcome drug resistance.
Conclusions:
- The ΔNp63α isoform is a significant therapeutic target in oncology.
- Developing strategies to inhibit ΔNp63α could lead to improved cancer patient outcomes.
- Further research into targeting ΔNp63α is warranted to combat critical aspects of cancer progression.
More Related Videos
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Nucleolus
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...